Federal Ruling Offers Some Regulatory Clarity For Biosimilars
On July 21, 2015, the Federal Circuit reached a momentous decision in the case of Amgen vs. Sandoz. The significance of this ruling goes well beyond the rights of these particular manufacturers, as the decision marks the first step toward clarifying the regulatory path for U.S. biosimilar manufacturers.
World Courier Biomedical Seminar 2015
The World Courier Biomedical Seminar is the global conference where pharmaceutical, research and regulatory leaders receive insight on the dynamic industry — and the impact on global specialty transport. You’ll collaborate with industry thought leaders to surface new and innovative ways to solve business challenges.
Advancing Research In Skin Biology with Metabolomics
This 30-minute webinar demonstrates how metabolomics can be a powerful tool in dermatological and skincare research.
Leveraging Metabolite Biomarkers For Clinical Trials
This 30-minute webinar will introduce a robust, highly sensitive biomarker development program that leverages a revolutionary metabolomics discovery platform to improve the range of analytes that can be measured routinely and reliably.
Tapping The Metabolome For Answers- A State Of The Art Approach
This 30-minute webinar provides a brief overview of recent advances in metabolomics technology and methodology, which together have advanced the field of metabolomics.